Tuesday's Top Afternoon Analyst Calls: Peloton, Biogen, Square, Lockheed Martin and More

Over halfway through the trading day on Tuesday, and the broad markets have yet to make up their minds. For the most part, the S&P 500 and Dow Jones industrial average have been trading sideways, albeit a little negative. The Nasdaq has picked up slightly, and the Russell 2000 is having the best showing out of the group.

With Congress finally coming to a consensus about another round of stimulus for the economy, investors would think that markets would be rallying on this positive news. However, Tuesday has proven to be a real stock-picker’s day.

To help divine which stocks could be rising or falling as a result of these developments, 24/7 Wall St. is taking a look at some big analyst calls that we have seen so far today. We have included the most recent analyst call on the stock, as well as a recent trading history and the general consensus among analysts.

For those that might have missed it, 24/7 Wall St. had an earlier round of analysts calls on Tuesday.

Biogen Inc. (NASDAQ: BIIB) was maintained as Buy at Canaccord Genuity. However, the firm did cut its price target to $359 from $393. The consensus price target is $291.40. Biogen stock was last seen trading at $248.08, in a 52-week range of $223.25 to $374.99.

Healthpeak Properties Inc. (NYSE: PEAK) was reiterated as Buy at Stifel with a $34 price target. The consensus price target is $30.56, and the stock was trading at $29.64. The 52-week range is $18.63 to $37.64.

IQVIA Holdings Inc. (NYSE: IQV) was reiterated at Stifel with a Buy rating and a $227 price target, compared to the most recent closing price of $176.75. The stock has traded in a range of $81.79 to $180.99 over the past 52 weeks. The consensus price target is $199.89.

Leslie’s Inc. (NASDAQ: LESL) was reiterated with a Buy rating and a $29 price target at Jefferies. The brokerage firm noted that Leslie’s is looking to build its outlook on what has been a record year. The stock was recently trading at $24.31, with a 52-week range of $19.15 to $25.84. Analysts have a consensus price target of $24.78.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.